每經(jing)AI快訊，振(zhen)德醫(yi)療（SH 603301，收盤價：46.75元(yuan)）10月(yue)10日晚間(jian)發布公(gong)(gong)告稱，振(zhen)德醫(yi)療用(yong)品股(gu)(gu)(gu)(gu)(gu)(gu)份(fen)(fen)(fen)有(you)(you)限(xian)(xian)(xian)公(gong)(gong)司第(di)三屆董事會第(di)四次會議(yi)審議(yi)通過(guo)《關于以集中競(jing)價交(jiao)易方(fang)式(shi)回購(gou)股(gu)(gu)(gu)(gu)(gu)(gu)份(fen)(fen)(fen)方(fang)案的議(yi)案》。現(xian)將(jiang)公(gong)(gong)司2022年9月(yue)30日前十大(da)無限(xian)(xian)(xian)售條件股(gu)(gu)(gu)(gu)(gu)(gu)東披露如下：浙(zhe)江振(zhen)德控股(gu)(gu)(gu)(gu)(gu)(gu)有(you)(you)限(xian)(xian)(xian)公(gong)(gong)司持(chi)(chi)(chi)(chi)約(yue)(yue)(yue)1.09億股(gu)(gu)(gu)(gu)(gu)(gu)，占(zhan)(zhan)(zhan)(zhan)比(bi)48.06%；沈振(zhen)芳持(chi)(chi)(chi)(chi)931萬(wan)(wan)(wan)(wan)股(gu)(gu)(gu)(gu)(gu)(gu)，占(zhan)(zhan)(zhan)(zhan)比(bi)4.1%；中國工商(shang)銀行股(gu)(gu)(gu)(gu)(gu)(gu)份(fen)(fen)(fen)有(you)(you)限(xian)(xian)(xian)公(gong)(gong)司－海富通改革驅(qu)動靈活配(pei)置混(hun)(hun)合型(xing)(xing)(xing)證(zheng)券(quan)投(tou)(tou)資(zi)(zi)基(ji)金(jin)持(chi)(chi)(chi)(chi)約(yue)(yue)(yue)332萬(wan)(wan)(wan)(wan)股(gu)(gu)(gu)(gu)(gu)(gu)，占(zhan)(zhan)(zhan)(zhan)比(bi)1.46%；泰(tai)康(kang)人壽保險有(you)(you)限(xian)(xian)(xian)責任(ren)公(gong)(gong)司－投(tou)(tou)連－行業配(pei)置持(chi)(chi)(chi)(chi)約(yue)(yue)(yue)313萬(wan)(wan)(wan)(wan)股(gu)(gu)(gu)(gu)(gu)(gu)，占(zhan)(zhan)(zhan)(zhan)比(bi)1.38%；交(jiao)通銀行股(gu)(gu)(gu)(gu)(gu)(gu)份(fen)(fen)(fen)有(you)(you)限(xian)(xian)(xian)公(gong)(gong)司－創金(jin)合信(xin)數字經濟主題(ti)股(gu)(gu)(gu)(gu)(gu)(gu)票型(xing)(xing)(xing)發起式(shi)證(zheng)券(quan)投(tou)(tou)資(zi)(zi)基(ji)金(jin)持(chi)(chi)(chi)(chi)約(yue)(yue)(yue)296萬(wan)(wan)(wan)(wan)股(gu)(gu)(gu)(gu)(gu)(gu)，占(zhan)(zhan)(zhan)(zhan)比(bi)1.3%；招商(shang)銀行股(gu)(gu)(gu)(gu)(gu)(gu)份(fen)(fen)(fen)有(you)(you)限(xian)(xian)(xian)公(gong)(gong)司－安(an)信(xin)醫(yi)藥健康(kang)主題(ti)股(gu)(gu)(gu)(gu)(gu)(gu)票型(xing)(xing)(xing)發起式(shi)證(zheng)券(quan)投(tou)(tou)資(zi)(zi)基(ji)金(jin)持(chi)(chi)(chi)(chi)約(yue)(yue)(yue)264萬(wan)(wan)(wan)(wan)股(gu)(gu)(gu)(gu)(gu)(gu)，占(zhan)(zhan)(zhan)(zhan)比(bi)1.16%；通用(yong)技(ji)術集團投(tou)(tou)資(zi)(zi)管理有(you)(you)限(xian)(xian)(xian)公(gong)(gong)司持(chi)(chi)(chi)(chi)約(yue)(yue)(yue)237萬(wan)(wan)(wan)(wan)股(gu)(gu)(gu)(gu)(gu)(gu)，占(zhan)(zhan)(zhan)(zhan)比(bi)1.04%；南京銀行股(gu)(gu)(gu)(gu)(gu)(gu)份(fen)(fen)(fen)有(you)(you)限(xian)(xian)(xian)公(gong)(gong)司－博時優質鑫選(xuan)一(yi)年持(chi)(chi)(chi)(chi)有(you)(you)期混(hun)(hun)合型(xing)(xing)(xing)證(zheng)券(quan)投(tou)(tou)資(zi)(zi)基(ji)金(jin)持(chi)(chi)(chi)(chi)約(yue)(yue)(yue)223萬(wan)(wan)(wan)(wan)股(gu)(gu)(gu)(gu)(gu)(gu)，占(zhan)(zhan)(zhan)(zhan)比(bi)0.98%；婁(lou)張鈿(dian)持(chi)(chi)(chi)(chi)約(yue)(yue)(yue)190萬(wan)(wan)(wan)(wan)股(gu)(gu)(gu)(gu)(gu)(gu)，占(zhan)(zhan)(zhan)(zhan)比(bi)0.84%；中國工商(shang)銀行股(gu)(gu)(gu)(gu)(gu)(gu)份(fen)(fen)(fen)有(you)(you)限(xian)(xian)(xian)公(gong)(gong)司－中歐醫(yi)療健康(kang)混(hun)(hun)合型(xing)(xing)(xing)證(zheng)券(quan)投(tou)(tou)資(zi)(zi)基(ji)金(jin)持(chi)(chi)(chi)(chi)約(yue)(yue)(yue)165萬(wan)(wan)(wan)(wan)股(gu)(gu)(gu)(gu)(gu)(gu)，占(zhan)(zhan)(zhan)(zhan)比(bi)0.73%。前十大(da)流通股(gu)(gu)(gu)(gu)(gu)(gu)東合計(ji)持(chi)(chi)(chi)(chi)股(gu)(gu)(gu)(gu)(gu)(gu)約(yue)(yue)(yue)1.39億股(gu)(gu)(gu)(gu)(gu)(gu)，占(zhan)(zhan)(zhan)(zhan)比(bi)61.05%。

2022年(nian)1至6月份，振德醫(yi)療的營業收入構成(cheng)為：醫(yi)用敷料占比(bi)99.63%，其他(ta)占比(bi)0.0%。

振德醫療(liao)的總(zong)經理、董事長均是魯建國，男，52歲，學(xue)歷背景為大專。

截至發稿，振德醫療市值為125億元(yuan)。

道達號（daoda1997）“個(ge)股(gu)趨勢”提醒：
1. 振德醫療近30日內北向資金持股量減少15.39萬股，占流通股比例減少0.06%；
2. 近30日內無機構對振德醫療進行調研。
更多個(ge)股(gu)趨勢信息(xi)，請(qing)搜索微(wei)信公眾號(hao)“道(dao)達號(hao)”，回復“查詢(xun)”，領取免費查詢(xun)權限！

每經(jing)頭條（nbdtoutiao）——

(記者 蔡鼎)

免責(ze)聲明：本文內容與數據(ju)僅供參考，不構成投資建議(yi)，使用前請核實。據(ju)此操作(zuo)，風險自(zi)擔。